Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Hoping they provide an update soon

<< Previous

Bullboard Posts

Next >>

Comment by StockingUp21on Jun 07, 2021 2:01pm

102 Views

Post# 33341283

RE:RE:RE:RE:Hoping they provide an update soon

seems more every day like a a scam here. You people say wait until next month every month. Only goes down and now is summer vacation?

Actuarial wrote: You can choose to wait, or, you can sell your shares and walk away. Investing into a development stage bio / pharm company, ups and downs are the norm. Is it a surprise to you?

Layth1990 wrote: Summer vacation ? We already have been on a vacation since Q4 2021 as they postponed ph3 . If this is true then we will hit 3$ and will keep on bleeding.